var singsData = [{"date":new Date(2012,1,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Benchmark downgrades BRCM to Hold from Buy.","showOnAxis":true},{"date":new Date(2012,1,21),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Auriga upgrades BRCM to Buy from Hold. Target Price is $44; previously $37.","showOnAxis":false},{"date":new Date(2012,10,26),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Benchmark upgrades BRCM to Buy from Hold. Target Price is $40; previously $32.","showOnAxis":false},{"date":new Date(2012,11,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wedbush maintains BRCM to Outperform. Target Price is $41; previously $39.","showOnAxis":true},{"date":new Date(2012,2,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Auriga maintains BRCM to Buy. Target Price is $45; previously $44.","showOnAxis":true},{"date":new Date(2012,3,26),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, BRCM reports 2012 Q1's earning $0.15 per share and revenue $1827MM..","showOnAxis":false},{"date":new Date(2012,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BRCM to Buy. Target Price is $45; previously $40.","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $43; previously $42.","showOnAxis":true},{"date":new Date(2012,5,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BRCM to Overweight. Target Price is $42; previously $45.","showOnAxis":true},{"date":new Date(2012,5,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Cantor Fitzgerald initiates coverage on BRCM to Buy. Target Price is $40.","showOnAxis":true},{"date":new Date(2012,6,24),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, BRCM reports 2012 Q2's earning $0.72 per share and revenue $1970MM. This beats analyst's estimated EPS $0.67, beats estimated revenue $1950MM.","showOnAxis":false},{"date":new Date(2012,7,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bernstein upgrades BRCM to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2012,7,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura downgrades BRCM to Neutral from Buy.","showOnAxis":true},{"date":new Date(2012,8,18),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades BRCM to Outperform from Sector Perform. Target Price is $46.","showOnAxis":false},{"date":new Date(2012,8,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"ISI Group maintains BRCM to Buy. Target Price is $44; previously $43.","showOnAxis":true},{"date":new Date(2012,8,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Brean Capital initiates coverage on BRCM to Buy. Target Price is $42.","showOnAxis":true},{"date":new Date(2012,9,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wedbush maintains BRCM to Outperform. Target Price is $39; previously $41.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, BRCM reports 2012 Q3's earning $0.79 per share and revenue $2130MM. This beats analyst's estimated EPS $0.76, beats estimated revenue $2090MM.","showOnAxis":false},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital maintains BRCM to Outperform. Target Price is $40; previously $42.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BRCM to Overweight. Target Price is $40; previously $42.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains BRCM to Outperform. Target Price is $45; previously $50.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"DA Davidson maintains BRCM to Buy. Target Price is $44; previously $45.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BRCM to Buy. Target Price is $40; previously $44.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $44; previously $43.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BRCM to Buy. Target Price is $40; previously $42.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BRCM to Buy. Target Price is $37; previously $42.","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains BRCM to Buy. Target Price is $45; previously $49.","showOnAxis":true},{"date":new Date(2013,0,29),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, BRCM reports 2012 Q4's earning $0.76 per share and revenue $2080MM. This beats analyst's estimated EPS $0.73, beats estimated revenue $2060MM.","showOnAxis":false},{"date":new Date(2013,0,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Cantor Fitzgerald maintains BRCM to Buy. Target Price is $39; previously $40.","showOnAxis":true},{"date":new Date(2013,0,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BRCM to Buy. Target Price is $39; previously $40.","showOnAxis":true},{"date":new Date(2013,0,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $42; previously $44.","showOnAxis":true},{"date":new Date(2013,0,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BRCM to Buy. Target Price is $35; previously $37.","showOnAxis":true},{"date":new Date(2013,0,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Societe Generale maintains BRCM. Target Price is $36.5; previously $37.","showOnAxis":true},{"date":new Date(2013,0,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains BRCM to Buy. Target Price is $43; previously $45.","showOnAxis":true},{"date":new Date(2013,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Evercore Partners initiates coverage on BRCM to Overweight. Target Price is $40.","showOnAxis":true},{"date":new Date(2013,1,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"PiperJaffray initiates coverage on BRCM to Overweight. Target Price is $50.","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Cowen & Co. initiates coverage on BRCM to Outperform.","showOnAxis":true},{"date":new Date(2013,11,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Charter Equity upgrades BRCM to Buy from Market Perform.","showOnAxis":false},{"date":new Date(2013,11,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BRCM to Buy. Target Price is $36; previously $32.","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BRCM to Buy. Target Price is $34; previously $31.","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Evercore Partners maintains BRCM to Overweight. Target Price is $34; previously $30.","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains BRCM to Buy. Target Price is $32; previously $30.","showOnAxis":true},{"date":new Date(2013,11,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains BRCM to Neutral. Target Price is $30; previously $27.","showOnAxis":true},{"date":new Date(2013,11,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer downgrades BRCM to Perform from Outperform; previously $37.","showOnAxis":true},{"date":new Date(2013,3,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays downgrades BRCM to Underweight from Overweight.","showOnAxis":true},{"date":new Date(2013,3,23),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, BRCM reports 2013 Q1's earning $0.65 per share and revenue $2010MM. This beats analyst's estimated EPS $0.56, beats estimated revenue $1910MM.","showOnAxis":false},{"date":new Date(2013,3,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BRCM to Buy. Target Price is $38; previously $35.","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains BRCM to Buy. Target Price is $45; previously $43.","showOnAxis":true},{"date":new Date(2013,5,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Topeka initiates coverage on BRCM to Buy. Target Price is $42.","showOnAxis":true},{"date":new Date(2013,6,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Lazard downgrades BRCM to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,6,23),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"BRCM reports 2013 Q2's earning $0.7 per share and revenue $2090MM. This beats analyst's estimated EPS $0.68, misses estimated revenue $2100MM.","showOnAxis":false},{"date":new Date(2013,6,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pacific Crest downgrades BRCM to Sector Perform from Outperform.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"B. Riley downgrades BRCM to Neutral from Buy. Target Price is $32; previously $45.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital downgrades BRCM to Market Perform from Outperform. Target Price is $30; previously $40.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BRCM to Underweight. Target Price is $26; previously $28.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Brean Capital maintains BRCM to Buy. Target Price is $36; previously $40.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup downgrades BRCM to Neutral from Buy. Target Price is $34; previously $41.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Cowen & Co. maintains BRCM to Outperform. Target Price is $37; previously $42.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse downgrades BRCM to Neutral from Outperform.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BRCM to Buy. Target Price is $36; previously $41.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Evercore Partners maintains BRCM to Overweight. Target Price is $35; previously $40.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $40; previously $44.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains BRCM to Buy. Target Price is $36; previously $40.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JMP Securities maintains BRCM to Market Outperform. Target Price is $34; previously $38.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BRCM to Overweight. Target Price is $40; previously $45.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BRCM to Buy. Target Price is $38; previously $40.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Mizuho downgrades BRCM to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Needham maintains BRCM to Buy. Target Price is $36; previously $39.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BRCM to Buy. Target Price is $36; previously $33.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"PiperJaffray maintains BRCM to Overweight. Target Price is $47; previously $51.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital downgrades BRCM to Sector Perform from Outperform. Target Price is $31; previously $45.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains BRCM to Buy. Target Price is $38; previously $45.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Topeka maintains BRCM to Buy. Target Price is $35; previously $42.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wedbush maintains BRCM to Outperform. Target Price is $36; previously $38.","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"William Blair downgrades BRCM to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2013,7,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades BRCM to Neutral from Buy. Target Price is $30; previously $36.","showOnAxis":true},{"date":new Date(2013,7,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS downgrades BRCM to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,7,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $32; previously $40.","showOnAxis":true},{"date":new Date(2013,7,5),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Drexel Hamilton upgrades BRCM to Buy from Hold. Target Price is $38.","showOnAxis":false},{"date":new Date(2013,8,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Standpoint Research initiates coverage on BRCM to Buy. Target Price is $33.","showOnAxis":true},{"date":new Date(2013,8,17),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Susquehanna upgrades BRCM to Positive from Neutral. Target Price is $35; previously $33.","showOnAxis":false},{"date":new Date(2013,8,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"CLSA upgrades BRCM to Outperform from Underperform.","showOnAxis":false},{"date":new Date(2013,8,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital maintains BRCM to Market Perform. Target Price is $27; previously $30.","showOnAxis":true},{"date":new Date(2013,8,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BRCM to Buy. Target Price is $34; previously $38.","showOnAxis":true},{"date":new Date(2013,9,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Drexel Hamilton initiates coverage on BRCM to Hold. Target Price is $30.","showOnAxis":true},{"date":new Date(2013,9,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BRCM to Buy. Target Price is $32; previously $34.","showOnAxis":true},{"date":new Date(2013,9,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BRCM to Buy. Target Price is $33; previously $36.","showOnAxis":true},{"date":new Date(2013,9,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains BRCM to Buy. Target Price is $30; previously $36.","showOnAxis":true},{"date":new Date(2013,9,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wedbush downgrades BRCM to Neutral from Outperform. Target Price is $27; previously $33.","showOnAxis":true},{"date":new Date(2013,9,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bernstein maintains BRCM to Outperform. Target Price is $30.","showOnAxis":true},{"date":new Date(2014,0,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"B. Riley upgrades BRCM to Buy from Neutral. Target Price is $37; previously $29.","showOnAxis":false},{"date":new Date(2014,0,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains BRCM to Neutral. Target Price is $33; previously $30.","showOnAxis":true},{"date":new Date(2014,0,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Evercore Partners maintains BRCM to Overweight. Target Price is $35; previously $34.","showOnAxis":true},{"date":new Date(2014,0,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $34; previously $32.","showOnAxis":true},{"date":new Date(2014,0,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains BRCM to Buy. Target Price is $34; previously $32.","showOnAxis":true},{"date":new Date(2014,10,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades BRCM to Buy from Neutral. Target Price is $48; previously $40.","showOnAxis":false},{"date":new Date(2014,11,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Brean Capital maintains BRCM to Buy. Target Price is $53; previously $46.","showOnAxis":true},{"date":new Date(2014,11,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Evercore ISI Group upgrades BRCM to Buy from Hold. Target Price is $55; previously $45.","showOnAxis":false},{"date":new Date(2014,3,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"ISI Group initiates coverage on BRCM to Neutral. Target Price is $32.","showOnAxis":true},{"date":new Date(2014,3,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"PiperJaffray assumes BRCM to Neutral. Target Price is $34.","showOnAxis":true},{"date":new Date(2014,3,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Needham downgrades BRCM to Hold from Buy. Target Price is $33.","showOnAxis":true},{"date":new Date(2014,4,19),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades BRCM to Outperform from Sector Perform. Target Price is $40; previously $33.","showOnAxis":false},{"date":new Date(2014,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura downgrades BRCM to Neutral from Buy. Target Price is $30; previously $33.","showOnAxis":true},{"date":new Date(2014,5,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Benchmark downgrades BRCM to Hold from Buy.","showOnAxis":true},{"date":new Date(2014,5,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wells Fargo downgrades BRCM to Underperform from Market Perform.","showOnAxis":true},{"date":new Date(2014,5,3),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"CLSA upgrades BRCM to Buy from Outperform.","showOnAxis":false},{"date":new Date(2014,5,3),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wedbush upgrades BRCM to Outperform from Neutral.","showOnAxis":false},{"date":new Date(2014,5,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains BRCM to Neutral. Target Price is $33; previously $27.","showOnAxis":true},{"date":new Date(2014,5,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $39; previously $35.","showOnAxis":true},{"date":new Date(2014,5,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BRCM to Buy. Target Price is $44; previously $37.","showOnAxis":true},{"date":new Date(2014,5,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BRCM to Neutral. Target Price is $38; previously $30.","showOnAxis":true},{"date":new Date(2014,5,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel downgrades BRCM to Hold from Buy; previously $34.","showOnAxis":true},{"date":new Date(2014,5,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Drexel Hamilton upgrades BRCM to Buy from Hold.","showOnAxis":false},{"date":new Date(2014,5,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Standpoint downgrades BRCM to Hold from Buy.","showOnAxis":true},{"date":new Date(2014,5,5),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades BRCM to Equal-weight from Underweight. Target Price is $40; previously $28.","showOnAxis":false},{"date":new Date(2014,5,5),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Exane BNP Paribas upgrades BRCM to Neutral from Underperform. Target Price is $35; previously $26.","showOnAxis":false},{"date":new Date(2014,6,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains BRCM to Neutral. Target Price is $40; previously $33.","showOnAxis":true},{"date":new Date(2014,6,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BRCM to Buy. Target Price is $47; previously $45.","showOnAxis":true},{"date":new Date(2014,6,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $45; previously $39.","showOnAxis":true},{"date":new Date(2014,6,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BRCM to Overweight. Target Price is $48; previously $39.","showOnAxis":true},{"date":new Date(2014,6,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie maintains BRCM to Outperform. Target Price is $45; previously $42.","showOnAxis":true},{"date":new Date(2014,6,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BRCM to Neutral. Target Price is $40; previously $38.","showOnAxis":true},{"date":new Date(2014,6,9),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Oppenheimer upgrades BRCM to Outperform from Market Perform. Target Price is $45.","showOnAxis":false},{"date":new Date(2014,9,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains BRCM to Outperform. Target Price is $48; previously $50.","showOnAxis":true},{"date":new Date(2014,9,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity maintains BRCM to Buy. Target Price is $45; previously $46.","showOnAxis":true},{"date":new Date(2014,9,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains BRCM to Outperform. Target Price is $44; previously $46.","showOnAxis":true},{"date":new Date(2015,0,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JMP Securities downgrades BRCM to Market Perform from Market Outperform. Target Price is $41.","showOnAxis":true},{"date":new Date(2015,1,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BRCM to Equal-Weight. Target Price is $43; previously $40.","showOnAxis":true},{"date":new Date(2015,2,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity downgrades BRCM to Hold from Buy. Target Price is $47; previously $50.","showOnAxis":true},{"date":new Date(2015,2,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Tigress Financial downgrades BRCM to Buy from Strong Buy.","showOnAxis":true},{"date":new Date(2015,2,30),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Nomura upgrades BRCM to Buy from Neutral. Target Price is $50; previously $40.","showOnAxis":false},{"date":new Date(2015,3,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BRCM to Equal-Weight. Target Price is $46; previously $43.","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Benchmark maintains BRCM to Hold. Target Price is $45; previously $40.","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BRCM to Buy. Target Price is $55; previously $50.","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BRCM to Buy. Target Price is $55; previously $52.","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BRCM to Buy. Target Price is $60; previously $50.","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Susquehanna maintains BRCM to Positive. Target Price is $54; previously $52.","showOnAxis":true},{"date":new Date(2015,3,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Ladenburg Thalmann initiates coverage on BRCM to Buy. Target Price is $51.","showOnAxis":true},{"date":new Date(2015,4,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"CLSA downgrades BRCM to Outperform from Buy.","showOnAxis":true},{"date":new Date(2015,4,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades BRCM to Neutral from Buy. Target Price is $58; previously $53.","showOnAxis":true},{"date":new Date(2015,4,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie downgrades BRCM to Neutral from Outperform. Target Price is $54.5.","showOnAxis":true},{"date":new Date(2015,4,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley downgrades BRCM to Equal-Weight from Overweight. Target Price is $58.","showOnAxis":true},{"date":new Date(2015,4,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Susquehanna downgrades BRCM to Neutral from Positive.","showOnAxis":true},{"date":new Date(2015,4,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Tigress Financial downgrades BRCM to Neutral from Buy.","showOnAxis":true},{"date":new Date(2015,6,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer downgrades BRCM to Perform from Outperform.","showOnAxis":true},{"date":new Date(2015,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity maintains BRCM to Hold. Target Price is $54.5; previously $59.","showOnAxis":true},{"date":new Date(2015,7,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wedbush downgrades BRCM to Neutral from Outperform. Target Price is $54; previously $61.","showOnAxis":true},{"date":new Date(2015,9,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"B. Riley downgrades BRCM to Neutral from Buy. Target Price is $55; previously $60.","showOnAxis":true},{"date":new Date(2016,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bernstein downgrades BRCM to Market Perform from Outperform.","showOnAxis":true}];